These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26686252)

  • 1. Thalidomide for hereditary haemorrhagic telangiectasia.
    Franchini M; Lippi G
    Lancet Haematol; 2015 Nov; 2(11):e457-8. PubMed ID: 26686252
    [No Abstract]   [Full Text] [Related]  

  • 2. Deep vein thrombosis induced by thalidomide to control epistaxis secondary to hereditary haemorrhagic telangiectasia.
    Penaloza A; Vekemans MC; Lambert C; Hermans C
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):616-8. PubMed ID: 21885956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life.
    Baysal M; Ümit EG; Kırkızlar HO; Özdöver AC; Demir AM
    Turk J Haematol; 2019 Feb; 36(1):43-47. PubMed ID: 29880465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taking thalidomide out of rehab.
    Akhurst RJ
    Nat Med; 2010 Apr; 16(4):370-2. PubMed ID: 20376039
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study.
    Invernizzi R; Quaglia F; Klersy C; Pagella F; Ornati F; Chu F; Matti E; Spinozzi G; Plumitallo S; Grignani P; Olivieri C; Bastia R; Bellistri F; Danesino C; Benazzo M; Balduini CL
    Lancet Haematol; 2015 Nov; 2(11):e465-73. PubMed ID: 26686256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide for Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia: A Preliminary Study.
    Fang J; Chen X; Zhu B; Ye H; Zhang W; Guan J; Su K
    Otolaryngol Head Neck Surg; 2017 Aug; 157(2):217-221. PubMed ID: 28418273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review.
    Harrison L; Kundra A; Jervis P
    J Laryngol Otol; 2018 Oct; 132(10):866-871. PubMed ID: 30191780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia.
    Lebrin F; Srun S; Raymond K; Martin S; van den Brink S; Freitas C; Bréant C; Mathivet T; Larrivée B; Thomas JL; Arthur HM; Westermann CJ; Disch F; Mager JJ; Snijder RJ; Eichmann A; Mummery CL
    Nat Med; 2010 Apr; 16(4):420-8. PubMed ID: 20364125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term therapy with thalidomide in hereditary hemorrhagic telangiectasia: case report and literature review.
    Chen CH; Hsu HH; Hu RH; Lee PH; Ho CM
    J Clin Pharmacol; 2012 Sep; 52(9):1436-40. PubMed ID: 22031620
    [No Abstract]   [Full Text] [Related]  

  • 10. Thalidomide Effects in Patients with Hereditary Hemorrhagic Telangiectasia During Therapeutic Treatment and in Fli-EGFP Transgenic Zebrafish Model.
    Peng HL; Yi YF; Zhou SK; Xie SS; Zhang GS
    Chin Med J (Engl); 2015 Nov; 128(22):3050-4. PubMed ID: 26608985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia.
    Colombo G; Bortolotti F; Chiapponi V; Buttini F; Sonvico F; Invernizzi R; Quaglia F; Danesino C; Pagella F; Russo P; Bettini R; Colombo P; Rossi A
    Int J Pharm; 2016 Nov; 514(1):229-237. PubMed ID: 27863666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia.
    Wang XY; Chen Y; Du Q
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1114-6. PubMed ID: 23661527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide for Hereditary Hemorrhagic Telangiectasia With Pulmonary Arterial Hypertension.
    Nakamura T; Ogo T; Tahara N; Fukui S; Tsuji A; Ueda J; Fukumoto Y; Nakanishi N; Ogawa H; Yasuda S
    Circ J; 2018 Mar; 82(4):1205-1207. PubMed ID: 28794352
    [No Abstract]   [Full Text] [Related]  

  • 14. Tranexamic acid and bevacizumab in hereditary hemorrhagic telangiectasia patients presenting with epistaxis.
    Lacout A; Marcy PY; El Hajjam M; Lacombe P
    Cutis; 2013 Apr; 91(4):173-4. PubMed ID: 23763075
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary arteriovenous malformations etiologies in HHT patients and potential utility of thalidomide.
    Lacout A; Marcy PY; El Hajjam M; Lacombe P
    Med Hypotheses; 2013 May; 80(5):587-8. PubMed ID: 23452644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: a case report and review of treatment options.
    Flanagan BA; Collins C; Parra S
    Cutis; 2012 Feb; 89(2):69-72. PubMed ID: 22474728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of tranexamic acid in a patient with hereditary hemorrhagic telangiectasia and massive epistaxis].
    Pérez del Molino A; Zarrabeitia R; Fernández A; Botella LM
    Med Clin (Barc); 2004 Jun; 123(3):118-9. PubMed ID: 15225479
    [No Abstract]   [Full Text] [Related]  

  • 18. Nintedanib as a novel treatment option in hereditary haemorrhagic telangiectasia.
    Kovacs-Sipos E; Holzmann D; Scherer T; Soyka MB
    BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28652319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of Thalidomide treatment in patients with Hereditary Haemorrhagic Telangiectasia.
    Hosman A; Westermann CJ; Snijder R; Disch F; Mummery CL; Mager JJ
    Rhinology; 2015 Dec; 53(4):340-4. PubMed ID: 26735132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional bleomycin injections for the palliation of epistaxis in hereditary hemorrhagic telangiectasia.
    Duncan IC; Van Der Nest L
    AJNR Am J Neuroradiol; 2004 Aug; 25(7):1144-6. PubMed ID: 15313698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.